Arcturus Therapeutics Holdings Inc (ARCT) FY2025Q3 Earning Prediction
Arcturus Therapeutics Holdings Inc (ARCT) is set to release its earnings performance on 11/10 05:00:00 in After Hours trading. Consensus forecasts predict a revenue of 16.00M and an earnings per share (EPS) of -1.25 for the . With Intellectia's exclusive AI algorithms, users can predict whether the earnings will beat or miss expectations before the report drops. Leverage this powerful tool to strategize and position your trades ahead of the earnings release!
Earnings Surprise Analysis
ARCT Transcript
The earnings call summary and Q&A reveal mixed signals. While there are positive developments in product pipelines and regulatory progress, management's lack of specific guidance on revenue and clinical endpoints creates uncertainty. The Q&A highlighted potential for growth but also pointed to uncertainties in clinical trial outcomes and commercial revenues. No major catalysts like new partnerships or strong financial metrics were announced, leading to a neutral sentiment overall.
The earnings call presents a mixed picture: strong pipeline developments with FDA fast track designation and cash runway extension are positives, but declining revenue and a net loss are negatives. The Q&A reveals cautious optimism about CF and OTC programs, yet management's lack of clarity on competitor impact and data release timing raises uncertainties. These factors, combined with no new partnerships or shareholder return changes, suggest a neutral stock movement prediction.
The earnings call reveals a decline in revenue and increased net loss, alongside an extended cash runway due to cost reductions and facility consolidation. The Q&A session highlights uncertainties, with management avoiding clear answers on key milestones and guidance. Despite a decrease in expenses, the lack of anticipated revenue milestones until 2028 and unclear regulatory feedback contribute to a negative sentiment. While some operational efficiencies were achieved, the overall financial outlook and management's vague responses suggest a negative stock price movement in the short term.
The earnings call reveals several negative financial indicators: a significant revenue drop, increased operating expenses, and a larger net loss. Despite some positive developments like the KOSTAIVE launch and strategic partnerships, the financial health and guidance issues weigh heavily. The Q&A section shows management's reluctance to provide clear guidance, adding uncertainty. These factors, along with a lack of strong positive catalysts, suggest a negative sentiment. Without market cap data, we assume a moderate negative reaction in stock price, likely between -2% and -8%.
ARCT Report
Frequently Asked Questions
What is the Arcturus Therapeutics Holdings Inc FY2025Q3 Earnings Release Date and Time?
Arcturus Therapeutics Holdings Inc (ARCT) is scheduled to release its FY2025Q3 earnings report onNov 10, 2025, After Hours(approximately 4:00 PM ET). This timing allows investors to react during after-hours trading, with a conference call typically following shortly after.
What Are the Consensus Forecasts for Arcturus Therapeutics Holdings Inc FY2025Q3 Revenue and EPS?
Analysts' consensus predicts 16.00M in revenue and an EPS of -1.00 for Arcturus Therapeutics Holdings Inc's FY2025Q3.
What Does Intellectia's AI Predict for Arcturus Therapeutics Holdings Inc FY2025Q3 Earnings?
Intellectia's exclusive AI algorithms forecast a forArcturus Therapeutics Holdings Inc's FY2025Q3 earnings, with a prediction date of Nov 10, 2025. Arcturus Therapeutics Holdings Inc
How Can I Use This Earnings Prediction to Trade ARCT Stock?
Leverage Intellectia's AI forecast to position trades ahead of theNov 10, 2025 release—consider calls for a beat scenario or protective puts for misses. Focus on pre-market volatility, and use the scenario probabilities to build strategies around revenue and guidance updates.
How Accurate Is Intellectia's AI for Earnings Predictions Like Arcturus Therapeutics Holdings Inc FY2025Q3?
Intellectia's predictions are backed by rigorous backtesting, showing a high hit rate for Beat and Miss calls compared to traditional analysis. While no forecast is 100% certain, we provide probability-based scenarios (e.g., 50% chance of a *Beat*) and detailed rationales to help you make informed decisions. Combine our insights with your strategy for the best results—it's like having a co-pilot for earnings season! Empowering users to strategize trades before reports drop.
How does AI Earnings Prediction generate its forecasts?
AI Earnings Prediction uses advanced Large Language Models (LLMs) to analyze a wealth of data, including past earnings transcripts, real-time market sentiment, analyst insights, and company news from the last three months. It focuses on key indicators like revenue, EPS, and margins to predict whether a company will *Beat*, *Miss*, or remain Neutral relative to market expectations. Think of it as a super-smart analyst crunching numbers and news 24/7 to give you a trading edge!
When are the predictions available, and how often are they updated?
Predictions are generated two days before a company’s earnings release (e.g., 5:00 PM ET on Feb 13 for a Feb 15 report) to capture the latest market and company data. They’re updated in real-time if significant news breaks, ensuring you get fresh insights.
Can I use AI Earnings Prediction for all types of stocks?
Currently, AI Earnings Prediction focuses on companies with market caps above $40 billion, covering major players like SPG, AAPL, MSFT, and NVDA for the 2025-2026 earnings seasons. We prioritize high-impact stocks with robust data to ensure reliable forecasts. Stay tuned as we expand coverage to more companies based on user demand!
